Speak directly to the analyst to clarify any post sales queries you may have.
The veterinary diagnostic market is rapidly refining its strategic priorities as transformative technologies, evolving regulations, and growing expectations for speed and accuracy shape animal health solutions. Senior decision-makers are navigating a landscape where proactive adaptation, operational flexibility, and collaboration define competitive edge amid shifting market demands.
Veterinary Diagnostic Market Snapshot
The global veterinary diagnostic market experienced growth from USD 3.63 billion in 2024 to USD 3.89 billion in 2025, with a projected CAGR of 7.72% reaching USD 6.59 billion by 2032. This sustained expansion reflects the integration of advanced instrumentation, molecular breakthroughs, and increasing digitalization of laboratory workflows. North America and Asia-Pacific are notable contributors due to strong research capabilities, mature regulations, and rising rates of pet ownership, driving continued advancement and investment. Solution portfolios now cater to both high-throughput laboratory settings and point-of-care environments, empowering organizations to meet a wide range of diagnostic challenges.
Scope & Segmentation of the Veterinary Diagnostic Market
This report delivers a holistic analysis designed for senior leaders seeking strategic clarity in a complex marketplace. Key segmentation areas include:
- Product Type: Instruments, reagents, software, and services; these also encompass consulting, data management, and specialized training for optimized user outcomes.
- Animal Type: Focus areas include aquaculture, companion animals, equine, livestock, and poultry, each with distinct diagnostic needs and regulatory requirements.
- Test Type: Clinical biochemistry, hematology, imaging, immunodiagnostics, microbiology, and molecular diagnostics—serving both routine screening and complex disease identification.
- Sample Type: Options such as serum and plasma, tissue, urine, and whole blood enable a spectrum of accurate diagnostic procedures.
- Technology: The market benefits from flow cytometry, immunoassays, next-generation sequencing, and polymerase chain reaction (PCR), accelerating test reliability and versatility.
- Disease Type: Assessed segments span genetic disorders, infectious diseases including bacterial, fungal, parasitic, and viral, as well as metabolic and neoplastic disorders.
- End User: Academic and research institutes, diagnostic laboratories, point-of-care settings, and veterinary hospitals each drive unique adoption trends and solution requirements.
- Region: Analysis extends across the Americas, Europe, Middle East and Africa, and Asia-Pacific, featuring detailed insights for key countries such as the United States, China, Germany, and India.
- Company Coverage: The report evaluates leading players, such as Zoetis Inc., IDEXX Laboratories, and Thermo Fisher Scientific, highlighting their innovation strategies, acquisitions, and product portfolio expansions.
Key Takeaways for Senior Decision-Makers
- Digital transformation within veterinary laboratories is optimizing diagnostic workflows and supporting more accurate, data-driven decision-making processes.
- Companion animal diagnostics are driving overall market momentum, propelled by demand for timely, wellness-oriented testing options, while livestock and poultry segments put a premium on biosecurity and herd health management.
- Emerging molecular and imaging technologies are advancing early disease identification and enabling greater precision in treatment planning.
- Strategic partnerships, ongoing R&D investment, and adoption of modular technology platforms are enhancing product lifecycles and strengthening the end-user experience.
- Geographic diversity brings opportunities for tailored go-to-market strategies, as infrastructure sophistication, regulatory demands, and veterinary practices differ by region.
- Expanded training, consulting, and post-sale support offerings are increasingly vital for vendors to differentiate and add long-term value for clients navigating evolving animal health landscapes.
Tariff Impact and Supply Chain Adaptation
Introduction of new tariffs by the United States in 2025 has influenced sourcing decisions and supplier negotiations within the veterinary diagnostic supply chain. In response, industry stakeholders are focusing on procurement agility, vendor diversification, and prioritization of regional manufacturing partnerships to sustain cost-effectiveness and supply stability. These strategies are shifting competitive dynamics and elevating the importance of value-added services in supplier selection.
Veterinary Diagnostic Market Methodology & Data Sources
The research leverages secondary sources, industry literature, and regulatory documentation, complemented by primary interviews with professional veterinarians, technology specialists, and regulatory experts. Data triangulation and expert workshops validate findings to offer reliable, actionable guidance tailored for senior leaders focused on empirical evidence and practicality.
Why This Report Matters
- Provides actionable insights to help executives align innovation, procurement, and regional growth initiatives with evolving market dynamics.
- Comprehensive segmentation supports optimized decisions on technology adoption, product development, and targeted market entry strategies.
- The report equips organizations with competitive clarity, equipping leaders to anticipate risks and capitalize on new opportunities within a dynamic animal health environment.
The veterinary diagnostic sector is advancing through the adoption of new technologies, evolving operational models, and increased collaboration. Organizations that leverage these market insights can enhance outcomes and strengthen their competitive positioning as the industry progresses.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this Veterinary Diagnostic market report include:- Zoetis Inc.
- Virbac S.A.
- IDEXX Laboratories, Inc.
- Neogen Corporation
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Agrolabo S.p.A.
- Biogal Galed Labs
- BioMérieux S.A.
- BioNote USA, Inc.
- Demeditec Diagnostics GmbH
- Eurofins Scientific SE
- Fassisi GmbH
- FUJIFILM Holdings Corporation
- Mars, Incorporated
- Promega Corporation
- Randox Laboratories, Ltd.
- Shenzhen Mindray Animal Medical Technology Co., Ltd.
- Vimian Group AB
- SAN Group Biotech Germany GmbH
- Meridian Bioscience, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | October 2025 |
Forecast Period | 2025 - 2032 |
Estimated Market Value ( USD | $ 3.89 Billion |
Forecasted Market Value ( USD | $ 6.59 Billion |
Compound Annual Growth Rate | 7.7% |
Regions Covered | Global |
No. of Companies Mentioned | 23 |